Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2026-01-07 @ 1:55 PM
Study NCT ID:
NCT01955694
Status:
COMPLETED
Last Update Posted:
2021-07-16
First Post:
2013-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-11-11
Start Date Type:
ACTUAL
Primary Completion Date:
2015-01-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-02-20
Completion Date Type:
ACTUAL
First Submit Date:
2013-09-30
First Submit QC Date:
None
Study First Post Date:
2013-10-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-15
Last Update Post Date:
2021-07-16
Last Update Post Date Type:
ACTUAL